While APOE ɛ4 is the major genetic risk factor for late-onset AD [59], our results also underscore the need for powerful genome-wide and polygenic approaches to studying complex phenotypes such as clinical outcome and brain changes following TBI. The gene discussed is APOE; the disease is Alzheimer disease.